AI assistant
Sending…
Nykode Therapeutics ASA — Director's Dealing 2024
Mar 8, 2024
3695_dirs_2024-03-08_3df88482-98d2-4f98-a3a8-859811641f6d.html
Director's Dealing
Open in viewerOpens in your device viewer
Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider
Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider
Oslo, Norway, March 8, 2024 - Primary insider Bernd R. Seizinger, Member of the Board of Directors of Nykode Therapeutics ASA, has today acquired 25,000 shares in Nykode Therapeutics ASA at an average price of NOK 14.81 per share. Following the transaction, Bernd R. Seizinger holds 625,000 shares in Nykode Therapeutics ASA.
Please see further details in the attached document.
More from Nykode Therapeutics ASA
Interim / Quarterly Report
2026
May 27
Earnings Release
2026
May 27
Report Publication Announcement
2026
May 18
Report Publication Announcement
2026
May 18
Declaration of Voting Results & Voting Rights Announcements
2026
May 13
Report Publication Announcement
2026
May 13
Regulatory Filings
2026
May 7
Capital/Financing Update
2026
May 7
Investor Presentation
2026
Apr 30
Investor Presentation
2026
Apr 30